Delivery Order SPE2DX22D0010-SPE2D825FFZ07
Award Date
5/29/25
Potential Completion Date
5/30/25
Potential Value
$11K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $29,021.99 and a period of performance through April 28, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price, non-set-aside contract with a ceiling value of $1,854.50 and a period of performance through April 16, 2025. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Vyvanse 50 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $5,793.01 and a period of performance through May 9, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,783.60, is for the delivery of Vyvanse 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price contract with an ultimate completion date of January 2, 2025. This contract is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,739.63 firm fixed-price contract is for the delivery of Vyvanse capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is not set aside and has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vyvanse 50 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The delivery order has a ceiling value of $1,310.89 and a performance period ending on May 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vyvanse 30 mg capsules, a medication used to treat ADHD. The contract has a ceiling value of $1,337.70 and a performance period extending through May 7, 2025. It is a firm fixed-price contract and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Vyvanse 10 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a ceiling value of $1,405.62 and a period of performance ending on May 6, 2025. It is a firm-fixed-price contract, indicating a pre-determined price for the supplies. The contract is not...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Vyvanse 60 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a firm fixed price, with a ceiling value of $4,738.40, and a performance period ending on May 20, 2025. This contract is not set aside for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Vyvanse 60 mg capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a firm-fixed-price delivery order with a ceiling value of $1,399.56 and an ultimate completion date of September 19, 2024. This order is part of a larger Indefinite Delivery Contract...